Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,595.1
31.9 (1.24%)

 

  • STI Straits Times Index
    2,595.1
    31.9 (1.24%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.3
    14.6 (0.94%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,249.5
    5.5 (0.02%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,331.2
    11.9 (0.36%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,272.3
    428.4 (1.88%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,237.1
    3.7 (0.07%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 535.4M
  • Value: 505.1M
  • Rise: 182
  • Fall: 62
  • Unch: 564

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.023+0.005
Medtecs Intl1.590+0.180
QT Vascular0.008+0.001
ThaiBev0.610+0.010
Sembcorp Marine0.245-0.105
UMS1.170+0.090
Rex Intl0.184+0.002
Genting Sing0.725+0.020
IPS Securex0.117+0.005
YZJ Shipbldg SGD0.960+0.010

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ESPERION THERAPEUTICS INC ESPERION THERAPEUTICS INC
Updated on 12 Aug 2020 (End of trading day)
Last (USD): 33.690 Change: +0.210 High: 34.440 Remarks: -
Change (%): +0.63 Low: 33.340
Open 33.530 Yesterday's Close 33.48
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 907,619 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -3.51825 Trailing EPS (USD) e -3.04015 NAV (USD) b -
PE a - Trailing PE f - Price / NAV b -
Dividend (USD) d - Cash In Hand (USD) g 10.8080 Issued & Paid-up Shares c 27,617,400
Dividend Yield (%) d - Price / Cash In Hand g 3.117 Treasury Shares h -
Market Cap (M) 930.430 Enterprise Value (M) 930.430
Piotroski F Score 1 Exchange Code ESPR Par Value ( $ ) n.a.
52 Weeks Volatility (%) 73.00 Free Float (%) 96.7
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 07 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ESPERION THERAPEUTICS INC NASDAQ 930.430 - - - -
Industry Biotechnology NASDAQ 2,796.433 438.295 6455.431 6.9965 0.664
Local Peer AMGEN INC NASDAQ 141,573.954 18.053 19.396 13.2821 2.423
Local Peer GILEAD SCIENCES INC NASDAQ 86,306.085 16.024 - 4.7876 3.697
Local Peer VERTEX PHARMACEUTICAL NASDAQ 70,547.487 59.948 33.904 9.3823 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 65,149.123 30.792 21.836 7.1929 -
Local Peer ILLUMINA INC NASDAQ 50,244.440 50.144 72.503 11.0113 -
Local Peer BIOGEN INC NASDAQ 46,420.538 7.883 7.832 4.1049 -
Local Peer MODERNA INC NASDAQ 27,431.688 - - 9.3087 -
Local Peer SEATTLE GENETICS INC NASDAQ 27,628.984 - - 15.2303 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,526.601 9.369 26.624 2.1473 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 21,402.927 - 175.064 6.6126 -
Local Peer INCYTE CORPORATION NASDAQ 20,605.820 46.108 - 8.7886 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 19,195.242 - - 7.5682 -
Other Local Peers BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), FIBROGEN INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), INSMED INC (NASDAQ), ALKERMES PLC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), ALLOVIR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), TG THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIELA BIO INC (NASDAQ), VAXCYTE INC (NASDAQ), VERACYTE INC (NASDAQ), XENCOR INC (NASDAQ), UNIQURE N.V. (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CORTEXYME INC (NASDAQ), EPIZYME INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), REGENXBIO INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ARVINAS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), MORPHIC HOLDING INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), PRECIGEN INC (NASDAQ), NKARTA INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), PASSAGE BIO INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), PERSONALIS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), IMMATICS N V (NASDAQ), AKOUOS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), AGENUS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), ARDELYX INC (NASDAQ), GERON CORP (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), XBIOTECH INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), KAMADA (NASDAQ), MERUS B V (NASDAQ), MANNKIND CORPORATION (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), TREVENA INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AFFIMED N V (NASDAQ), MEDICINOVA INC (NASDAQ), NEXTCURE INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), CHIASMA INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), VERASTEM INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CHIMERIX INC (NASDAQ), XOMA CORP (NASDAQ), GLYCOMIMETICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CONTRAFECT CORP (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), INMUNE BIO INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ORGENESIS INC (NASDAQ), INFLARX N V (NASDAQ), SESEN BIO INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), VACCINEX INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), RESTORBIO INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), OCUGEN INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), COHBAR INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), CURIS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), SOLIGENIX INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ATYR PHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ADVAXIS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIOCARDIA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), EVOGENE LTD (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ)
Global Peer CSL ASX 127,919.225 47.679 44.159 14.7911 0.941
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer WUXI BIO HKEx 221,879.573 193.011 193.011 15.5155 -
Global Peer SINO BIOPHARM HKEx 173,250.468 56.447 56.964 5.0005 0.579
Global Peer BEIGENE HKEx 150,032.460 - - 7.6324 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 6,857.479 125.825 40.267 5.7203 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 29,632.014 - - 9.9344 -
Global Peer 3SBIO HKEx 23,324.354 21.125 21.125 2.1664 -
Global Peer HAOHAI BIOTEC HKEx 18,684.524 44.441 44.441 3.1767 0.729
Other Global Peers VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), MESOBLAST LTD (ASX), POLYNOVO LIMITED (ASX), ASCENTAGE-B (HKEx), FRONTAGE (HKEx), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NYSE), DPHARMA (Bursa), SINOMAB BIO-B (HKEx), LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), PFENEX INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), IBIO INC (NYSE American), TELIX PHARMACEUTIC (ASX), IMUGENE LIMITED (ASX), NEXT SCIENCE LTD (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), ANTEOTECH LIMITED (ASX), MEMPHASYS LTD (ASX), IMMUTEP LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), GENETIC TECHNOLOGIES (ASX), INVEX THERAPEUTICS LTD NPV (ASX), CYNATA THERAPEUTICS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), BIOTRON (ASX), CT ENTERPRISE (HKEx), ALTERITY THERAPEUTICS LIMITED (ASX), ORAGENICS INC (NYSE American), BIONOMICS LTD (ASX), BIOSINO BIO-TEC (HKEx), REGENEUS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), Suntar Eco-City (SGX), REGENT PACIFIC (HKEx), ACTINOGEN MEDICAL LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), RHINOMED LIMITED (ASX), PATRYS LIMITED (ASX), ADALTA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), HAO WEN H-NEW (HKEx), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), NANOLLOSE LTD (ASX), HAO WEN H-OLD (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --5.180
-13.33 %
10 Days --5.380
-13.77 %
20 Days --15.320
-31.26 %
Medium Term Return 3 Months --12.980
-27.81 %
6 Months --36.420
-51.95 %
1 Year --3.850
-10.26 %
Long Term Return 2 Years --12.270
-26.70 %
3 Years --14.620
-30.26 %
5 Years --23.850
-41.45 %
Annualised Return Annualised --
-10.15 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 24.820 - 76.980 Change From 1 Year Low +8.870 % Change From 1 Year Low (%) +35.74
Change From 1 Year High -43.290 % Change From 1 Year High (%) -56.24
2 Years Range 24.820 - 76.980 Change From 2 Years Low +8.870 % Change From 2 Years Low (%) +35.74
Change From 2 Years High -43.290 % Change From 2 Years High (%) -56.24
5 Years Range 9.400 - 82.680 Change From 5 Years Low +24.290 % Change From 5 Years Low (%) +258.40
Change From 5 Years High -48.990 % Change From 5 Years High (%) -59.25
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Esperion Therapeutics, Inc. engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. It offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

Historical Price Data

Date Open High Low Close Volume VWAP
12 Aug 2020 33.530 34.440 33.340 33.690 907,619 -
11 Aug 2020 35.940 36.200 32.630 33.480 1,932,164 -
10 Aug 2020 38.090 38.500 36.300 37.000 980,140 -
07 Aug 2020 38.490 39.110 37.940 38.000 645,558 -
06 Aug 2020 38.900 39.290 38.160 38.570 719,581 -
05 Aug 2020 39.890 39.890 38.100 38.870 900,014 -
04 Aug 2020 40.370 40.890 38.415 39.520 428,394 -
03 Aug 2020 38.090 41.480 37.650 40.420 925,657 -
31 Jul 2020 39.810 40.000 37.210 37.630 896,564 -
30 Jul 2020 38.420 40.290 38.090 39.780 394,093 -
29 Jul 2020 39.020 39.850 38.527 39.070 571,937 -
28 Jul 2020 40.610 40.830 39.120 39.130 561,326 -
27 Jul 2020 40.610 41.770 40.120 40.860 804,139 -
24 Jul 2020 43.740 43.740 38.730 39.970 1,235,790 -
23 Jul 2020 45.560 46.400 43.770 44.090 461,080 -
22 Jul 2020 46.750 46.750 45.310 46.030 359,432 -
21 Jul 2020 47.230 48.000 46.600 46.840 305,833 -
20 Jul 2020 48.240 48.390 46.410 46.910 620,411 -
17 Jul 2020 47.390 49.090 47.390 48.200 1,136,278 -
16 Jul 2020 48.460 48.560 47.310 47.450 377,496 -
15 Jul 2020 48.210 49.500 47.451 49.010 467,674 -
14 Jul 2020 47.450 48.220 45.630 47.420 564,431 -
Summary
Current 2 Weeks
(30 Jul 2020 to 12 Aug 2020)
38.420 41.480 32.630 33.690 8,729,784 -
Previous 2 Weeks
(16 Jul 2020 to 29 Jul 2020)
48.460 48.560 32.630 39.070 6,433,722 -
4 Weeks from
(17 Jun 2020 to 15 Jul 2020)
44.670 45.130 32.630 49.010 12,595,964 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.